Loading organizations...
§ Private Profile · Seattle, WA, USA
Biotechnology company reprogramming B cells with ISP technology into drug factories for rare genetic disorders, HIV, and muscle loss.
Immusoft, based in Seattle, Washington, develops Immune System Programming (ISP™) technology to reprogram patients' B cells into miniature drug factories, producing gene-encoded medicines for long-term treatment of diseases like rare genetic disorders, HIV, and muscle loss. The company maintains an employee count of 21-40. Immusoft has raised at least $5.74 million in venture funding, including a $2.74 million Series A in 2016 and a $3 million Series B in 2018. Investors include Founders Fund’s FF Science, Technium Partners, and 600 Mile Challenge Fund. Its scientific advisory board features Nobel laureate David Baltimore, while CEO Sean Ainsworth leads alongside Founder Matthew Scholz, who established Immusoft in 2009. Its business model centers on venture funding through equity rounds, including Series A and ongoing Series B, to advance clinical trials and development.
Immusoft has raised $34.1M across 5 funding rounds.
Immusoft has raised $34.1M in total across 5 funding rounds.
Immusoft has raised $34.1M in total across 5 funding rounds.
Immusoft's investors include Maria Millan, Alexandria Venture Investments, Breakout Ventures, DEFTA Partners, Mesa Verde Venture Partners, RBV Capital, Sean Ainsworth, Founders Fund, Technium Partners, Thiel Foundation.
Immusoft has raised $34.1M across 5 funding rounds. Most recently, it raised $8.0M Grant in January 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 27, 2023 | $8M Grant | Maria Millan | — | Announced |
| Jan 3, 2019 | $20M Series B | — | Alexandria Venture Investments, Breakout Ventures, DEFTA Partners, Mesa Verde Venture Partners, RBV Capital | Announced |
| Jan 5, 2018 | $3M Series B | Sean Ainsworth | — | Announced |
| Nov 11, 2016 | $2.7M Venture Round | Founders Fund, Technium Partners | — | Announced |
| Apr 21, 2012 | $350K Grant | Thiel Foundation | — | Announced |